Citation: Cm. Perry et Aj. Wagstaff, INTERFERON-ALPHA-N1 - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF CHRONIC VIRAL-HEPATITIS, Biodrugs, 9(2), 1998, pp. 125-154
Citation: Cm. Perry et S. Noble, SAQUINAVIR SOFT-GEL CAPSULE FORMULATION - A REVIEW OF ITS USE IN PATIENTS WITH HIV-INFECTION, Drugs, 55(3), 1998, pp. 461-486
Authors:
GEBHARD JR
PERRY CM
HARKINS S
LANE T
MENA I
ASENSIO VC
CAMPBELL IL
WHITTON JL
Citation: Jr. Gebhard et al., COXSACKIEVIRUS B3-INDUCED MYOCARDITIS - PERFORIN EXACERBATES DISEASE,BUT PLAYS NO DETECTABLE ROLE IN VIRUS CLEARANCE, The American journal of pathology, 153(2), 1998, pp. 417-428
Citation: Cm. Perry et Aj. Wagstaff, RECOMBINANT MAMMALIAN CELL-DERIVED SOMATROPIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF WASTING ASSOCIATED WITH HIV-INFECTION, Biodrugs, 8(5), 1997, pp. 394-414
Citation: Cm. Perry et P. Benfield, SERTRALINE - AN OVERVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND A REVIEW OF ITS THERAPEUTIC EFFICACY IN OBSESSIVE-COMPULSIVE DISORDER, CNS DRUGS, 7(6), 1997, pp. 480-500
Citation: Cm. Perry et R. Davis, GANCICLOVIR - A PHARMACOECONOMIC REVIEW OF ITS USE AS INTRAVENOUS OR ORAL-MAINTENANCE THERAPY IN THE MANAGEMENT OF CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS, PharmacoEconomics, 12(2), 1997, pp. 209-228
Authors:
GEBHARD JR
PERRY CM
MAHADEVIAH S
WHITTON JL
Citation: Jr. Gebhard et al., USE OF A NONVIRAL VECTOR TO EXPRESS A CHIMERIC TRANSFER-RNA-RIBOZYME AGAINST LYMPHOCYTIC CHORIOMENINGITIS VIRUS - CYTOPLASMIC ACCUMULATION OF A CATALYTICALLY COMPETENT TRANSCRIPT BUT MINIMAL ANTIVIRAL EFFECT, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(1), 1997, pp. 3-11
Citation: Cm. Perry et D. Faulds, LAMIVUDINE - A REVIEW OF ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF HIV-INFECTION, Drugs, 53(4), 1997, pp. 657-680
Citation: Cm. Perry et Ja. Balfour, DIDANOSINE - AN UPDATE ON ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF HIV DISEASE, Drugs, 52(6), 1996, pp. 928-962
Citation: Cm. Perry et D. Faulds, VALACICLOVIR - A REVIEW OF ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN HERPESVIRUS INFECTIONS, Drugs, 52(5), 1996, pp. 754-772
Citation: Cm. Perry et Rn. Brogden, CEFUROXIME AXETIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY, Drugs, 52(1), 1996, pp. 125-158
Citation: Cm. Perry et Rn. Brogden, GOSERELIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN BENIGN GYNECOLOGICAL DISORDERS, Drugs, 51(2), 1996, pp. 319-346
Citation: Cm. Perry et Hm. Bryson, OKA MERCK VARICELLA VACCINE - A REVIEW OF ITS IMMUNOGENICITY AND PROTECTIVE EFFICACY AGAINST VARICELLA/, CLINICAL IMMUNOTHERAPEUTICS, 4(5), 1995, pp. 396-416
Citation: Cm. Perry et D. Mctavish, ESTRAMUSTINE PHOSPHATE SODIUM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PROSTATE-CANCER, Drugs & aging, 7(1), 1995, pp. 49-74
Citation: Cm. Perry et Aj. Wagstaff, FAMCICLOVIR - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN HERPESVIRUS INFECTIONS, Drugs, 50(2), 1995, pp. 396-415
Citation: Cm. Perry et al., FLUCONAZOLE - AN UPDATE OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN VAGINAL CANDIDIASIS, Drugs, 49(6), 1995, pp. 984-1006
Citation: Rj. Quaglia et Cm. Perry, A STUDY OF UNDERLYING VARIABLES AFFECTING ASPIRATIONS OF RURAL ADOLESCENTS, Adolescence, 30(117), 1995, pp. 233-243
Citation: Cm. Perry et Cl. Johnson, FAMILIES AND SUPPORT NETWORKS AMONG AFRICAN-AMERICAN OLDEST-OLD, International journal of aging & human development, 38(1), 1994, pp. 41-50